20 Clinical characteristics of pathological confirmed early onset dementia with lewy bodies

Simon Kang Seng Ting, Celeste Chen, Huihua Li, Shahul Hameed, Adeline Su Lyn Ng, Eng‐King Tan, Kok Pin Ng, Nagaendran Kandiah2019 · DOI

Introduction

Early-onset dementia (EOD), defined as the onset of symptoms before the age of 65, presents a unique set of clinical challenges compared to late-onset dementia (LOD). While Alzheimer’s Disease (AD) is the most recognized form of cognitive decline in younger populations, Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia. Despite its prevalence, the clinical profile of early-onset DLB (EODLB) is frequently misunderstood, leading to suboptimal diagnosis rates that hinder effective treatment and patient outcomes.

This study addresses the diagnostic gap by hypothesizing that EODLB possesses a distinct clinical and neuropsychiatric profile compared to early-onset Alzheimer’s Disease (EOAD). By utilizing pathologically confirmed data, the research aims to identify the specific markers that can help clinicians differentiate these two conditions more accurately.

Methods

The researchers conducted a retrospective analysis using data from the National Alzheimer’s Coordinating Center (NACC) database, a comprehensive longitudinal dataset aggregated from NIA-funded Alzheimer’s Disease Centers across the United States.

To ensure the highest level of diagnostic accuracy, the study focused on patients with pathologically confirmed diagnoses rather than clinical impressions alone. The cohort included 363 patients with EOAD, 32 with EODLB, and 147 with late-onset DLB (LODLB). The analysis compared baseline demographics, cognitive performance (via neuropsychological battery scores), behavioral symptoms, and motor symptoms across three groups: EODLB versus EOAD, and EODLB versus LODLB.

The Diagnostic Gap: A High Rate of Misidentification

One of the most striking findings of the study is the high rate of clinical misdiagnosis. Nearly half of the patients with pathologically confirmed EODLB (46.9%) were initially misdiagnosed as having EOAD ($p < 0.0001$).

This discrepancy suggests that current diagnostic frameworks, which are often heavily weighted toward memory and executive function, are insufficient for identifying DLB in younger patients. Because EOAD is the "default" diagnosis for early-onset cognitive decline, the specific motor and psychiatric markers of DLB are frequently overlooked or attributed to other causes.

Clinical Profiles: EODLB vs. EOAD

The study identified several key clinical features that distinguish EODLB from EOAD. While EOAD patients typically present with memory impairment as their primary and most prominent symptom, EODLB patients exhibit a more diverse range of symptoms at onset:

  • Motor Symptoms: EODLB patients were significantly more likely to present with motor symptoms—such as physical slowness (bradykinesia) and tremors—as their first recognized sign of illness.
  • Neuropsychiatric Markers: Psychosis, apathy, and REM sleep behavioral disorder (RBD) were significantly more prevalent in the EODLB group.
  • Caregiver Observations: Caregiver reports of agitation and apathy were found to be significant predictors in differentiating EODLB from EOAD.
  • Cognitive Performance: Interestingly, neuropsychological tests were found to be less reliable for differentiation. While EOAD patients generally performed worse on memory-specific assessments, both groups showed overlapping deficits in other cognitive domains, making standard cognitive testing a weak tool for definitive diagnosis in early-onset cases.

The research also highlighted that EODLB is not simply a younger version of the late-onset disease. When comparing EODLB to LODLB, several differences emerged:

  • Mood and Cognition: EODLB patients were found to be more depressed than their late-onset counterparts.
  • Cognitive Preservation: Despite their psychiatric symptoms, EODLB patients actually performed better on memory and executive function tests than LODLB patients, suggesting that the cognitive trajectory of DLB may be slower or different in younger brains.

Conclusion and Clinical Implications

The high rate of misdiagnosis (46.9%) for EODLB underscores an urgent need for a more comprehensive clinical approach. The study suggests that clinicians should move beyond a memory-centric diagnostic model when evaluating younger patients.

To improve diagnostic accuracy, clinicians should prioritize the evaluation of:

  1. Motor function, specifically looking for bradykinesia.
  2. Sleep history, with a focus on REM sleep behavioral disorder.
  3. Neuropsychiatric symptoms, including visual hallucinations and apathy.

By integrating these markers into the initial assessment, the medical community can improve the detection of EODLB, ensuring that patients receive appropriate management for their specific symptoms and pathology. Future research should focus on developing screening tools tailored to younger populations that emphasize these non-cognitive markers.

Summary updated

Abstract

<h3>Background</h3> Early-onset dementia (EOD) is characterized by distinct clinical profiles and prognosis when compared to late-onset dementia (LOD). As the second most common neurodegenerative form of dementia, little is known about the clinical profile of early-onset Dementia with Lewy Bodies (DLB). A current challenge for clinicians when managing patients with DLB is the suboptimal diagnosis rate which will affect treatment efficacy and outcome. To address this knowledge gap, by hypothesizing early-onset DLB will have a distinct profile when compared to Alzheimer’s disease (AD), we accessed and reviewed data of patients with pathological confirmed DLB from National Alzheimer’s Coordinating Center (NACC) database. <h3>Methods</h3> Patients with first visit that fulfill criteria for dementia of AD or DLB were analyzed. Early onset age was defined as less than 65 years old. Variables included in the analyses include baseline demographics, cognitive, behavioral, motor symptoms, neuropsychological battery scores and clinician diagnosis. Comparisons were made between early-onset AD (EOAD) versus early-onset DLB (EODLB), and early versus late-onset DLB. <h3>Results</h3> This study included 363 patients with EOAD, 32 EODLB and 147 late-onset DLB. Patients with EODLB were more likely to present with psychosis, apathy, REM sleep behavioral disorder, and motor symptoms. While EOAD patients were more likely to present with cognitive symptoms as first recognized and predominant presentation and perform worse in memory assessment. Motor as first recognized presentation, slowness, visual hallucination, caregiver reporting of agitation and apathy were the significant predictors to differentiate the two. Late-onset DLB patients were less depressed and more impaired in memory and executive function related scores than EODLB. Significant number of EODLB patients were misdiagnosed as EOAD (46.9%, p&lt;0.0001). <h3>Conclusions</h3> EODLB is characterized by motor and neuropsychiatric symptoms while neuropsychological tests appear less reliable to differentiate EODLB from EOAD. Given that misdiagnosis of DLB remain significantly high, we propose a more careful and comprehensive clinical approach may improve the diagnosis rate. <h3>Acknowledgement</h3> The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by these NIA funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Steven Ferris, PhD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI Marie-Francoise Chesselet, MD, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD) , P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), and P50 AG047270 (PI Stephen Strittmatter, MD, PhD). This study is supported by Singhealth Foundation Grant (NRS 15/001), NNI Centre Grant (NCG CS02) and National Medical Research Council, Singapore (NMRC/IRG/015).
BibTeX
@misc{ting2019clinical,
  author = {Simon Kang Seng Ting and Celeste Chen and Huihua Li and Shahul Hameed and Adeline Su Lyn Ng and Eng‐King Tan and Kok Pin Ng and Nagaendran Kandiah},
  title = {{20 Clinical characteristics of pathological confirmed early onset dementia with lewy bodies}},
  year = {2019},
  doi = {10.1136/jnnp-2019-bnpa.20},
}
Figure